Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the addition of an up-to-date operating status notice (including NIH Clinical Center status and links). Deletion of the previous version tag v3.1.0. overall, indicates a maintenance refresh with updated operating status information.
    Difference
    2%
    Check dated 2025-10-06T05:36:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    - Added new page revision tag: v3.1.0. - Removed several cancer-related topic terms (e.g., Neoplasms by Histologic Type, Carcinoma, Carcinoma, Ovarian Epithelial) and an older revision tag v3.0.2, indicating pruning of topics and a version update.
    Difference
    0.5%
    Check dated 2025-09-29T03:07:27.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:23:43.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T16:19:41.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has added significant content related to immunotherapy and cancer research, including a new facility name and location, while removing various cancer types and related resources.
    Difference
    8%
    Check dated 2025-08-31T11:57:25.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:23:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.